[Emerging and drug-resistant infectious diseases--carbapenem resistant bacterial infections].
Arakawa
Y
Y
D000421:Alcaligenes / Q000187:drug effects / Q000201:enzymology; D015780:Carbapenems / Q000494:pharmacology*; D003428:Cross Infection / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000201:enzymology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology*; D016958:Pseudomonas putida / Q000187:drug effects / Q000201:enzymology; D012706:Serratia marcescens / Q000187:drug effects / Q000201:enzymology*; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics
D015780:Carbapenems; D001618:beta-Lactamases